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AbsTrACT
Objective to assess the association of symptoms of 
depression and anxiety with sexual risk behaviour and 
history, among women and heterosexual men attending 
genitourinary medicine (gUM) clinics.
Methods attitudes to and Understanding of risk 
of acquisition of HiV (aUraH) was a cross-sectional, 
self-administered questionnaire study recruited from 
20 gUM clinics in england, 2013–2014. this analysis 
included women and heterosexual men. the prevalence 
of depression and anxiety symptoms was assessed. 
Modified Poisson regression was used to produce 
adjusted prevalence ratios (aPr) for the association 
of t demographic, socioeconomic and lifestyle factors 
with depression and anxiety, adjusted for gender, 
age, ethnicity, education level and study region. 
among individuals reporting sex in the past 3 months, 
associations of depression and anxiety with sexual 
risk behaviour and history were assessed separately 
by gender, adjusted for age, ethnicity, study region, 
education and relationship status.
results Questionnaires were completed by 676 women 
and 470 heterosexual men. Depression symptoms were 
reported by 100 (14.8%) women and 33 men (7.0%). 
anxiety symptoms were reported by 79 women (11.7%) 
and 21 men (4.5%). among women reporting recent 
sex, those with depression symptoms were more likely to 
report condomless sex with a non-regular partner, aPr 
1.38 (1.07–1.77) and recent condomless sex with two 
or more partners, 1.80 (1.25–2.59). Women with anxiety 
symptoms more likely to report recent condomless 
sex with two or more partners, 1.68 (1.13–2.50), low 
self-efficacy for condom use, 1.54 (1.02–2.31) and Sti 
diagnosis in the last year 1.51 (1.04–2.20). among 
heterosexual men reporting recent sex, depression and 
anxiety symptoms were associated with low self-efficacy 
with condom use, 2.32 (1.29–4.19) for depression and 
2.23 (1.26–3.94) for anxiety, but not with measures of 
condomless sex.
Discussion the associations between psychological 
symptoms and sexual risk behaviours highlight the 
importance of holistic assessment of need by both 
general and sexual health clinicians. We highlight the 
challenge in delivering holistic care associated with 
fragmentation of sexual health services.
InTrODuCTIOn
There is a strong association between depression 
and risk factors for chronic illness, for example, 
smoking, alcohol1–3 and between depression and 
chronic disease.4 However, establishing a causal 
relationship between mental and physical illness is 
complicated by difficulties in establishing tempo-
rality.1 A similar link between mood disorder and 
sexual health has been suggested.5 In a nation-
ally representative UK survey, men and women 
reporting treatment for depression were signifi-
cantly more likely to report condomless sex with 
two or more partners and to perceive themselves 
to be at high risk of STI compared with individuals 
with no symptoms of, and not on treatment for, 
depression.5 There is also evidence from the UK6 
and the USA7 that symptoms of poor mental health 
may be more common in attenders at sexual health 
clinics than in the general population.
The purpose of the ‘Attitudes to and Under-
standing of Risk of Acquisition of HIV’ (AURAH) 
study was to understand the characteristics of 
individuals at risk of STI and HIV infection to 
inform and target health promotion. This study 
was carried out in genitourinary medicine (GUM) 
clinics in England. Individuals attending GUM 
clinics in England may do so without referral and 
can be seen for various sexual and reproductive 
health issues. A number of international studies 
have analysed the relationship between depression 
and sexual risk behaviour, however few UK studies 
have focused on women and heterosexual men 
attending GUM clinics, and to our knowledge none 
have assessed the relationship between anxiety and 
sexual risk. A previous analysis of the AURAH study 
assessed the association of depressive symptoms 
with sexual behaviour among men who have sex 
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prevalence of depression and anxiety symptoms among women 
and heterosexual men; assess the association of demographic, 
socioeconomic and lifestyle factors, with depression and anxiety 
symptoms, and assess the association of depression and anxiety 
symptoms with self-reported sexual behaviour and history 
measures.
MeThODs
The AURAH methods have been described in detail elsewhere.9 
Briefly, AURAH was a cross-sectional questionnaire study that 
recruited individuals from 20 GUM clinics across England 
between June 2013 and November 2014. AURAH inclusion 
criteria were: HIV negative (or undiagnosed at recruitment), 
aged 18 years or over, and attending for a routine STI screen 
and/or HIV testing. Initially, study recruitment was unrestricted, 
after 6 months recruitment was targeted towards MSM and 
individuals of black ethnicity to ensure adequate representa-
tion of the demographic groups at particular risk of HIV. This 
analysis uses data collected from women and heterosexual men. 
Data collected from MSM have been analysed and reported 
separately.8
Participants completed a self-administered questionnaire from 
which the following information was derived.
sexual behaviour/history measures
Variables included: recent (in the previous 3 months) condomless 
vaginal or anal sex with (1) a non-regular partner/s, (2) ≥2 part-
ners or (3) a partner of unknown or positive HIV status; ≥2 new 
sexual partners within the previous year; STI diagnosis within 
the previous year; history of ever testing for HIV and self-effi-
cacy with condom use. Participants were deemed to demonstrate 
low self-efficacy if they disagreed/strongly disagreed with the 
statement, ‘I feel confident that, if I want to, I can make sure a 
condom is used during sex with any partner, in any situation,’ 
or if they agreed/strongly agreed with the statement, ‘I find it 
difficult to discuss condom use with any new sexual partner.’ 
For condomless sex measures and STI history, missing data were 
taken to indicate absence of the behaviour. This assumption was 
tested in a sensitivity analysis detailed below.
symptoms of depression and anxiety
Symptoms of depression and anxiety were assessed using the 
Patient Health Questionnaire (PHQ9)10 and General Anxiety 
Disorder (GAD7)11 screening tools. Participants are asked if they 
have experienced each PHQ9/GAD7 symptom in the previous 
2 weeks (with four possible responses from: ‘not at all’ to 
‘more than half the days’) coded 0–3. A PHQ9 score of ≥10 
(maximum score 27) was used to define depression symptoms, 
this has been widely validated10 and corresponds to moderate-se-
vere symptoms. PHQ2 scores were also calculated based on the 
first two PHQ9 symptoms to facilitate comparison with similar 
studies; a score of ≥3 indicates depression symptoms.5 8 A GAD7 
score of ≥10 (maximum score 21) was used to define anxiety 
symptoms.11 To account for the potential impact of treatment 
on active symptoms, participants were also asked if they were 
currently receiving any (medical or other) treatment for depres-
sion. Additional mesures of depression were defined in which 
participants reporting treatment for depression were included as 
well as those positive for PHQ9/PHQ2.
Demographic, socioeconomic and lifestyle data
Data included age, gender, ethnicity (White, Black African, Black 
Caribbean, other), relationship status (ongoing relationship with 
a partner/spouse —yes/no), study region (London or other), UK 
birth, employment (employed, student or unemployed/other), 
housing (home owner, rented or ‘unstable accommodation’ 
including temporary accommodation and homeless), financial 
hardship (participants were asked if they had sufficient money to 
meet basic needs, possible responses: yes, mostly, sometimes or 
no), education (university degree or not), recent (in the previous 
3 months) recreational drug use and smoking status (current, 
ex-smoker or non-smoker). Alcohol intake was assessed using the 
first two questions of the Alcohol Use Disorders Identification 
Test-Consumption12 tool (AUDIT-C): a score of ≥6 is taken to 
indicate higher risk drinking.
Analysis populations
The prevalence of depression and anxiety symptoms and their 
association with demographic, socioeconomic and lifestyle 
factors is reported in all women and heterosexual men. Indi-
viduals reporting no vaginal or anal sex in the last 3 months 
were excluded from the analyses assessing the associations 
of symptoms with sexual behaviour/history because previous 
studies have demonstrated an association between depression 
and lack of sexual activity,5 8 and we aimed to compare condom-
less sex with condom-protected sex. Women who identified as 
gay and those with missing data on sexuality were also excluded 
from the analysis of sexual behaviour/history; bisexual women 
were retained in this analysis. Although bisexual women may 
have unique risks for depression, the small numbers of women 
reporting that they were bisexual prevented their analysis as a 
separate group.
statistical analysis
The prevalence of depression and anxiety symptoms is presented 
with 95% CIs. χ2 tests were used to assess the unadjusted asso-
ciation of demographic, socioeconomic and lifestyle character-
istics with these symptoms. Modified Poisson regression models 
(Poisson models with log link and robust error variance) were 
used to assess the adjusted associations of each of these charac-
teristics with depression and anxiety symptoms. Each factor was 
considered separately with adjustment for age group, gender, 
ethnicity, study region and education. Modified Poisson regres-
sion was used to assess the relationship of depression and anxiety 
symptoms with sexual behaviour/history in individuals reporting 
recent sex, in women and in heterosexual men separately, with 
adjustment for age group, ethnicity, study region, education and 
relationship status. Associations are presented as adjusted prev-
alence ratios with 95% CIs (aPR/95% CI). Modified Poisson 
regression is an accepted alternative to logistic regression in the 
analysis of binary outcomes, the main advantage of which is that 
it estimates the readily interpretable prevalence ratio, rather 
than the OR.13
Statistical analysis was undertaken in Stata V.14.1.
sensitivity analysis
The association between psychological symptoms and sexual 
behaviour/history was explored with additional adjustment for 
higher risk alcohol use and recent recreational drug use, because 
previous studies have demonstrated a link between alcohol and 
drug use and sexual risk behaviour, and we aimed to assess 
evidence that these factors mediated the association between 
psychological symptoms and sexual risk behaviour.8
An additional sensitivity analysis was carried out excluding 
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Figure 1 Study recruitment, inclusions and exclusions.
Table 1 Demographic and socioeconomic characteristics of women 
and heterosexual men in AURAH
Women (n=676) Men (n=470)
n (%) n (%)
Age (years)
  <25 285 (43.4) 89 (19.4)
  25–29 140 (21.3) 151 (33.0)
  30–39 163 (24.8) 133 (29.0)
  40+ 68 (10.4) 85 (18.6)
Ethnicity
  White 163 (24.4) 146 (31.4)
  Black/mixed African 325 (48.7) 225 (48.4)
  Black/mixed Caribbean 114 (17.1) 54 (11.6)
  Other ethnicities 65 (9.7) 40 (8.6)
Study region
  London 412 (60.9) 350 (74.5)
  Outside London 264 (39.1) 120 (25.5)
UK born
  UK born 298 (45.7) 207 (44.7)
  Non-UK born 354 (54.3) 256 (55.3)
Relationship status
  In a relationship 465 (68.9) 302 (64.3)
  Not in a relationship 210 (31.1) 168 (35.7)
Education
  University degree 379 (56.2) 274 (58.3)
  Below university 295 (43.7) 196 (41.7)
Housing
  Home owner 84 (12.6) 71 (15.3)
  Renting 395 (59.4) 286 (61.8)
  Unstable/other 186 (28.0) 106 (22.9)
Work status
  Employed 360 (54.5) 430 (78.3)
  Student 199 (30.1) 62 (11.3)
  Unemployed/other* 102 (15.4) 57 (10.4)
Reports sufficient money for basic needs
  All of the time 318 (47.7) 275 (59.0)
  Most of the time 200 (30.0) 113 (24.2)
  Some of the time 103 (15.5) 46 (9.9)
  No 45 (6.8) 32 (6.9)
*includes retired and carer.
AURAH, Attitudes to and Understanding of Risk of Acquisition of HIV.
resulTs
There were 2630 participants in the AURAH study (response rate 
60%). Following exclusion of 1484 MSM there were 1146 indi-
viduals: 470 (41.0%) heterosexual men and 676 (59.0%) women. 
Of the women, 624 of 676 (92.3%) were heterosexual, 32 (4.7%) 
were bisexual, 3 (<1.0%) were gay and 17 missing (2.5%). Figure 1 
demonstrates recruitment, inclusions and exclusions.
Table 1 demonstrates the characteristics of all 676 women and 
470 heterosexual men in AURAH. The median age of women 
was 26 years, and of men was 29 years.
Prevalence of depression and anxiety symptoms
The prevalence of depression symptoms (PHQ9 ≥10) was 
14.8% among women and 7.0% among heterosexual men; 
corresponding prevalence for anxiety symptoms (GAD7 ≥10) 
was 11.7% and 4.5%. Symptoms of both depression and anxiety 
were reported by 62 women (9.2%) and by 14 men (3.0%) 
(table 2).
Demographic, socioeconomic and lifestyle factors: association 
with depression and anxiety symptoms
In the unadjusted analysis female gender, non-London study 
region, not being in a relationship, non-employment, financial 
hardship and current smoking were associated with depression 
symptoms (table 3), and there was some evidence of association 
with non-university education, rented or unstable housing and 
higher risk drinking. In adjusted models women were more than 
twice as likely as men to have depression symptoms, individuals 
not in a relationship were about 70% more likely to have depres-
sion symptom compared with those in a relationship, those 
reporting the most severe level of financial hardship were almost 
four times as likely to report depression symptoms as those with 
sufficient money, depression prevalence was almost twofold 
higher for current smokers compared with non-smokers, and for 
those reporting higher risk drikning, and was about 50% higher 
for those reporting recent recreational drug use. Associations of 
study region, education, work situation and housing with depres-
sion symptoms were attenuated after adjustment. Age, ethnicity 
and UK birth were not associated with depression symptoms in 
unadjusted or adjusted analysis.
Anxiety symptoms were associated with female gender, unem-
ployment, financial hardship, non-university education and 
current smoking in unadjusted analyses (table 3). These associ-
ations remained in adjusted analysis, except for the association 
with unemployment which was attenuated. In contrast to depres-
sion symptoms, no significant associations with anxiety symp-
toms were seen for relationship status, recent recreational drug 
use and higher risk drinking with anxiety symptoms. In addition, 
age group, ethnicity, study region, UK birth and housing status 
were not associated with anxiety symptoms.
Treatment for depression
Current medical or other treatment for depression was reported 
by 10/470 men, 2.1% (95% CI 1.0 to 3.9) and 37/676 women, 
5.5% (95% CI 3.9 to 7.5). In total, 41 men (8.7%, 95% CI 6.3 
to 11.6) and 122 (18.0%, 95% CI 15.2 to 21.2) women reported 
depression symptoms (PHQ9≥10) and/or current treatment, 
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Table 2 Prevalence of depression and anxiety symptoms in women and heterosexual men
Women n=676 heterosexual men n=470
n % (95% CI) n % (95% CI)
PHQ9 score
  0–4 No/minimal 451 66.7 (63.0 to 70.2) 362 77.0 (72.9 to 80.8)
  5–9 Mild 125 18.5 (15.7 to 21.7) 75 16.0 (12.8 to 19.6)
  10–14 Moderate 45 6.7 (4.9 to 8.8) 24 5.1 (3.3 to 7.5)
  15–19 Moderate-severe 41 6.1 (4.4 to 8,2) 5 1.1 (0.3 to 2.5)
  20–27 Severe 14 2.1 (1.1 to 3.5) 4 0.9 (0.2 to 2.2)
PHQ9 score ≥10 Depression symptoms 100 14.8 (12.2 to 17.7) 33 7.0 (4.9 to 9.7)
PHQ2* score ≥3 Depression symptoms 100 14.8 (12.2 to 17.7) 31 6.6 (4.6 to 9.3)
GAD7 score ≥10 Anxiety symptoms 79 11.7 (9.4 to 14.4) 21 4.5 (2.9 to 6.9)
PHQ9 ≥10 and GAD7 ≥10 Both depression and anxiety symptoms 62 9.2 (7.2 to 11.7) 14 3.0 (1.7 to 5.1)
*Based on first two PHQ9 questions.
GAD, General Anxiety Disorder; PHQ, Patient Health Questionnaire.
(95% CI 15.8 to 21.8) had depression symptoms by PHQ2 
(PHQ2 ≥3) and/or current treatment.
Association of depression and anxiety symptoms with sexual 
behaviours and sexual history
Sex in the last 3 months was reported by 582/676 (86.1%, 
83.2–88.6) women and 410/470 (87.2%, 83.7–90.0) men. The 
prevalence of each sexual behaviour/history measure and the 
adjusted association of depression and anxiety symptoms with 
these measures are shown in table 4, among 582 women and 410 
men who reported sex in the last 3 months (see figure 1).
After adjustment, there was some evidence of an association 
between depression symptoms and condomless sex in women, 
but little evidence of a similar association in men.
Women with depression symptoms were more likely to report 
recent condomless sex with a non-regular partner, aPR/95% CI 
1.38 (1.07 to 1.77), and recent condomless sex with two or more 
partners 1.80 (1.25 to 2.59). In women, there was no evidence 
of an association between depression symptoms and other sexual 
behaviour/history measures including low self-efficacy negoti-
ating condom use, reporting two or more new partners in the 
last year, or STI diagnosis in the previous year (see table 4).
Among men, after adjustment there was no significant rela-
tionship between depression symptoms and the sexual behav-
iour/history measures with the exception of low self-efficacy 
negotiating condom use, 2.32 (1.29–4.19).
Among women, anxiety symptoms were associated with 
reporting recent condomless sex with two or more partners, 
1.69 (1.13–2.50), low self-efficacy negotiating condom use, 1.54 
(1.02–2.31) and with history of STI diagnosis in the previous 
year, 1.51 (1.04–2.20).
In men, anxiety symptoms were associated with low self-ef-
ficacy in relation to condom use, 2.23 (1.26-3.94) but not with 
any other sexual behaviour or history measures.
sensitivity analysis
All reported associations between depression symptoms and 
anxiety symptoms, and sexual risk behaviours remained after 
additional adjustment for drug and alcohol use. Among women, 
effect sizes of depression and anxiety symptoms were somewhat 
attenuated for condomless sex with a non-regular partner and 
condomless sex with multiple partners (see online supplemen-
tary information). In men, the effect size of depression symp-
toms was slightly increased for low self-efficacy after adjustment 
for alcohol and drug use. These results suggest that alcohol and 
drug use influence, and may mediate, sexual risk behaviour but 
are not likely to be the sole mediators.
Exclusion of participants with missing data for condomless sex 
and STI history variables did not materially change the results.
DIsCussIOn
Principal findings
In this study of women and heterosexual men attending GUM 
clinics, symptoms of depression were reported by 14.8% of 
women and 7.0% of men and symptoms of anxiety were reported 
by 11.7% of women and 4.5% of men. There was a strong posi-
tive association between financial hardship and psychological 
symptoms, and a positive association between depression symp-
toms and measures of condomless sex in women. In addition, 
we report an association of anxiety symptoms with condomless 
sex, low self-efficacy for condom use and previous STI diagnosis 
in women. Among men, depression and anxiety were associ-
ated with low self-efficacy for condom use but not with other 
measures of sexual behaviour/history.
strengths and weaknesses
A strength of this study is the use of validated screening tools 
to assess depression and anxiety symptoms and the collection 
of detailed sexual behaviour data. Our work contributes to the 
evidence base on the association between psychological symp-
toms and sexual risk with a focus on individuals attending GUM 
clinics.
There are some important limitations. It is not possible in 
a cross-sectional study to determine causality or the direction 
of the association between psychological symptoms and sexual 
behaviour. It might reasonably be expected that anxiety symp-
toms could be provoked by, for example, recent high-risk sexual 
behaviour. However, the PHQ9 and GAD7 tools are validated 
for depression and anxiety screening and are intended to capture 
ongoing, clinically significant symptoms.10 11 Irrespective of the 
direction of association, in our study depression and/or anxiety 
symptoms were reported frequently and we demonstrate an asso-
ciation between these symptoms and some sexual risk behaviours. 
This suggests holistic assessment of sexual and mental health is 
likely to be useful in determining risk of poor sexual health. The 
measurement of sexual behaviours relies on self-report and may 
therefore be subject to recall error and bias, however it is likely 
that GUM clinic attenders would have good recall of recent 
sexual activity. Social desirability bias may influence reporting, 
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Table 3 Demographic, socioeconomic and lifestyle factors and association with depression and anxiety symptoms in women and heterosexual 
men
Depression symptoms: PhQ9 ≥10 Anxiety symptoms: GAD7 ≥10 
n/n (%) aPr* n/n (%) aPr*
Gender
  Male 33/470 (7.0) 1 21/470 (4.5) 1
  Female 100/676 (14.8) 2.08 (1.40–3.08) 79/676 (11.7) 2.82 (1.74–4.57)
P value <0.001 <0.001 <0.001 <0.01
Age (years)
  <25 54/376 (14.4) 1 38/376 (10.1) 1
  25–29 32/292 (11.0) 1.07 (0.69–1.58) 24/292 (8.2) 1.18 (0.72–1.93)
  30–39 30/300 (10.0) 0.83 (0.53–1.30) 23/300 (7.7) 0.90 (0.54–1.49)
  40+ 16/154 (10.4) 0.94 (0.55–1.61) 14/154 (9.1) 1.18 (0.67–2.08)
P value 0.28† 0.77 0.70 0.74
Ethnicity
  White 26/309 (8.4) 1 21/309 (6.8) 1
  Black African 65/550 (11.8) 1.39 (0.88–2.22) 47/550 (8.5) 1.11 (0.65–1.88)
  Black Caribbean 23/168 (13.7) 1.36 (0.80–2.31) 18/168 (10.7) 1.24 (0.68–2.28)
  Other ethnicities 17/105 (16.2) 1.81 (1.00–3.28) 12/105 (11.4) 1.53 (0.76–3.09)
P value 0.11 0.25 0.35 0.67
Study region
  London 76/761 (10.0) 1 59/761 (7.8) 1
  Not London 57/385 (14.8) 1.36 (0.97–1.90) 41/385 (10.6) 1.28 (0.85–1.91)
P value 0.02 0.08 0.10 0.24
UK born
  UK born 65/506 (12.8) 1 49/506 (9.7) 1
  Non-UK born 67/610 (11.0) 0.82 (0.56–1.19) 49/610 (8.0) 0.83 (0.53–1.29)
P value 0.24 0.3 0.33 0.41
Relationship status
  In a relationship 75/768 (9.8) 1 64/768 (8.3) 1
  Not in a relationship 58/378 (15.3) 1.73 (1.25–2.39) 36/378 (9.5) 1.27 (0.85–1.89)
P value <0.01 0.001 0.5 0.25
Work status
  Employed 68/697 (9.8) 1 53/697 (7.6) 1
  Student 36/261 (13.8) 1.12 (0.71–1.76) 22/261 (8.4) 0.90 (0.51–1.56)
  Unemployed/other§ 27/163 (16.6) 1.45 (0.95–2.21) 23/163 (14.1) 1.52 (0.95–2.45)
P value 0.02† 0.22 0.02 0.14
Education
  University degree 66/654 (10.1) 1 46/654 (7.0) 1
  Below university 67/491 (13.6) 1.28 (0.93–1.78) 54/491 (11.0) 1.47 (1.01–2.14)
P value 0.07 0.17 0.02 0.04
Housing
  Home owner 11/155 (7.1) 1 10/155 (6.5) 1
  Rented 79/682 (11.6) 1.57 (0.85–2.91) 59/682 (8.7) 1.29 (0.67–2.50)
  Unstable 41/292 (14.0) 1.66 (0.86–3.26) 28/292 (9.6) 1.33 (0.63–2.78)
P value 0.09 0.31 0.53 0.73
Reports sufficient money for basic needs 
  All the time 43/593 (7.3) 1 37/593 (6.2) 1
  Most of the time 39/313 (12.5) 1.50 (0.97–2.32) 22/313 (7.0) 0.92 (0.53-1/59)
  Some of the time 27/149 (18.1) 2.22 (1.39–3.53) 19/149 (12.8) 1.69 (0.97–2.94)
  No 21/77 (27.3) 3.79 (2.36–6.08) 19/77 (24.7) 3.65 (2.13–6.25)
P value <0.01 <0.001 <0.001 <0.001
Recent recreational drug use‡
  No 98/896 (10.9) 1 76/895 (8.5) 1
  Yes 35/250 (14.0) 1.47 (1.02–2.13) 24/250 (9.6) 1.32 (0.83–2.09)
P value 0.18 0.04 0.58 0.24
Alcohol—AUDIT-C ≥6
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Depression symptoms: PhQ9 ≥10 Anxiety symptoms: GAD7 ≥10 
n/n (%) aPr* n/n (%) aPr*
  Yes 16/95 (16.8) 1.95 (1.20–3.16) 6/95 (6.3) 0.89 (0.34–2.05)
P value 0.1 <0.01 0.39 0.79
Smoking status
  Non-smoker 68/664 (10.2) 1 55/664 (8.3) 1
  Ex-smoker 20/212 (9.4) 1.06 (0.66–1.70) 11/212 (5.2) 0.71 (0.38–1.33)
  Current smoker 45/248 (18.1) 1.92 (1.32–2.79) 32/248 (12.9) 1.59 (1.01–2.46)
P value <0.01 <0.01 0.01 0.02
*Adjusted for age, gender, ethnicity, education and study region.
†Test for linear trend.
‡Within the last 3 months.
§Other includes unable to work due to long-term health condition, carers and retired.
AUDIT-C, Alcohol Use Disorders Identification Test-Consumption; GAD, General Anxiety Disorder; PHQ, Patient Health Questionnaire; aPR, adjusted prevalence ratio.
Table 3 Continued
Table 4 Association of depression and anxiety symptoms with sexual behaviour and history measures in women and heterosexual men reporting 
sex in the last 3 months
sexual behaviour or 
history measure behaviour reported
PhQ9 ≥10 GAD7 ≥10
aPr† (95% CI) P value aPr† (95% CI) P value
Condomless sex with 
non-regular partner* 
Women 192/582 33.0% 1.38 (1.07 to 1.77) 0.01 1.15 (0.84 to 1.57) 0.39
Men 199/410 48.5% 0.88 (0.58 to 1.32) 0.53 0.81 (0.43 to 1.53) 0.53
Condomless sex with ≥2 
partners* 
Women 114/582 19.6% 1.80 (1.25 to 2.59) <0.01 1.68 (1.13 to 2.50) 0.01
Men 144/410 35.1% 0.57 (0.26 to 1.24) 0.15 0.35 (0.20 to 1.52) 0.25
Condomless sex with 
partner of unknown HIV 
status* 
Women 224/582 38.5% 1.14 (0.88 to 1.47) 0.33 1.05 (0.78 to 1.41) 0.77
Men 199/410 48.5% 0.77 (0.45 to 1.30) 0.33 1.14 (0.73 to 1.80) 0.56
Low self-efficacy 
negotiating condom use 
Women 121/566 21.4% 1.31 (0.87 to 1.96) 0.20 1.54 (1.02 to 2.31) 0.04
Men 82/392 20.9% 2.32 (1.29 to 4.19) 0.01 2.23 (1.26 to 3.94) 0.01
≥2 new partners in the 
last 12 months 
Women 165/572 28.8% 1.12 (0.80 to 1.55) 0.51 1.06 (0.72 to 1.56) 0.77
Men 215/395 54.4% 1.12 (0.86 to 1.48) 0.40 1.19 (0.83 to 1.69) 0.35
Diagnosed with an STI in 
the last 12 months 
Women 127/582 21.8% 1.22 (0.84 to 1.78) 0.30 1.51 (1.04 to 2.20) 0.03
Men 98/410 23.9% 1.06 (0.49 to 2.27) 0.89 0.80 (0.30 to 2.11) 0.65
Ever had an HIV test Women 466/573 81.3% 1.03 (0.92 to 1.14) 0.64 1.02 (0.91 to 1.14) 0.73
Men 317/403 78.7% 0.93 (0.74 to 1.18) 0.56 0.80 (0.55 to 1.16) 0.23
For exclusions see Figure 1.
*Within the last 3 months.
†Adjusted for age, ethnicity, study region, education and relationship status.
GAD, General Anxiety Disorder; PHQ, Patient Health Questionnaire; aPR, adjusted prevalence ratio.
of depression and anxiety. These biases may operate differ-
ently in women and heterosexual men, which could contribute 
to differences in results. Finally, the relatively small number of 
women and men reporting symptoms of both depression and 
anxiety prevented analysis of the association between comorbid 
depression and anxiety on sexual risk behaviour.
Comparison with the literature
In Natsal-3, Field et al considered reported depression symptoms 
(PHQ2 score ≥3) and pharmacological treatment for depres-
sion in estimating the prevalence of depression. They reported 
an overall prevalence of depression as 18.2% in women and 
11.9% in men.5 This compares to 18.7% of women in AURAH 
and 8.3% of men who had (PHQ2 ≥3) for depression and/
or treatment. The definition of treatment within the AURAH 
study included ‘medical therapy’ in addition to pharmacological 
treatment, this would be expected to result in somewhat higher 
estimations of depression prevalence. Consistent with previous 
prevalence studies,5 14 15 we demonstrated that depression and 
anxiety symptoms were more common among women than men, 
and were strongly associated with some markers of social depri-
vation. It is not possible to determine causality, however our 
study supports a relationship between poverty and psycholog-
ical symptoms which may operate in both directions. Clinicians 
should consider deprivation when assessing patients, and holistic 
services should support people in accessing financial support/
benefits as appropriate.
Among individuals who reported recent sex, depression 
symptoms were associated with condomless sex with a non-reg-
ular partner, and condomless sex with two or more partners in 
women, but not in men. Our findings are broadly consistent with 
evidence from cross-sectional and longitudinal studies from the 
USA,16–22 Canada23, and Eastern Europe22 that depression symp-
toms are associated with condomless sex,19 20 24 reporting multiple 
sexual partners17 18 21 and history of STI diagnosis.18 22 23 Our 
study demonstrates that the association between psychological 
symptoms and sexual risk behaviour is not limited to depression 
symptoms. We report a positive association between symptoms 
of anxiety and certain sexual risk behaviours in women. This is 
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Key messages
 ► Symptoms of at least moderate depression and/or anxiety 
were reported frequently by women and heterosexual men 
attending genitourinary medicine (GUM) clinics in England.
 ► In women, depression symptoms and anxiety symptoms 
were associated with sexual risk behaviours including recent 
condomless sex with a non-regular partner and reporting 
multiple recent condomless sex partners.
 ► Psychological symptoms were associated with low self-
efficacy for condom use among women and heterosexual 
men.
 ► The association between sexual and mental health should 
be considered both by general and GUM clinicians, and 
by commissioners of these services to ensure appropriate 
pathways are in place to support holistic care.
between symptoms of depression and anxiety, a number of indi-
viduals reported symptoms of anxiety only. Women in this group 
may be at increased risk of STI. Finally, we demonstrated an 
association between psychological symptoms and self-efficacy 
regarding condom use in women and heterosexual men. This 
finding is consistent with our previous analysis of MSM AURAH 
study participants.8
Interpretation and implications
There are a number of possible explanations for our findings. 
Common mental health disorders may be associated with 
impaired judgement and risk evaluation25 and have been linked 
to sexual impulsivity,26 which may contribute to taking sexual 
risks. Associations of depression and anxiety with low self-ef-
ficacy for condom use may suggest that low self-efficacy is an 
important mechanism in the link between psychological symp-
toms and sexual risk. Factors such as intimate partner violence 
were not measured in this study but may also impact on the 
dynamics between socioeconomic hardship, psychological symp-
toms and sexual risk behaviour among women. It is plausible 
that for all the associations described causality may operate in 
either direction and this is especially important to consider in the 
setting of a GUM clinic.
Our findings have implications for clinicians practising in 
specialist (GUM, mental health) and general (e.g. primary care) 
settings. Clinicians managing people with mental health prob-
lems should consider sexual health needs, and offer testing or 
signposting as needed. In GUM settings, screening for psycho-
logical symptoms may be useful in estimating risk of poor sexual 
health.5 In patients at moderate to high risk of HIV infection, 
the additional risk conferred by mental illness should be consid-
ered when evaluating the role for preventive measures such as 
pre-exposure prophylaxis against HIV infection, alongside an 
assessment of barriers to adherence and adherence support strat-
egies. GUM clinicians are skilled in supporting STI risk reduc-
tion strategies. Assessment of psychological symptoms in GUM 
settings may be particularly useful when working with service 
users presenting with multiple and/or repeated behaviours asso-
ciated with risk of STI and HIV acquisition.
In England, there are particular challenges in the delivery 
of holistic sexual healthcare due to budget cuts. Real-terms 
spending on public health decreased by approximately 5% 
between 2013/2014 and 2017/2018 and a recent review of 
the impact of financial pressures on healthcare services in the 
England highlighted that GUM services in particular are under 
considerable pressure as a result of budget reductions and 
increasing demand.27 Therefore, financial pressures pose a chal-
lenge to developing holistic pathways of care.
COnClusIOn
Our study demonstrates an association between depression 
symptoms and some measures of condomless sex and sexual risk 
among women and between anxiety symptoms and low self-ef-
ficacy for condom use among women and heterosexual men. 
Providers and commissioners of mental health and sexual health 
services should support the development of clinical care path-
ways which allow seamless referral between these services.
handling editor richard Oliver de Visser
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